What is Skyland Analytics?
Skyland Analytics offers intuitive, cloud-based process data management and analytics solutions specifically designed for emerging and global life science companies. Their platform is engineered to enhance visibility and streamline data management across the entire product lifecycle and supply chain, with a particular emphasis on cell and gene therapy organizations. By facilitating efficient data gathering and analysis from R&D through commercial manufacturing, Skyland Analytics aims to modernize operations, replacing outdated legacy systems and spreadsheets with cost-effective, agile solutions that drive operational efficiency and support regulatory compliance.
How much funding has Skyland Analytics raised?
Skyland Analytics has raised a total of $1M across 2 funding rounds:
Private Equity
$889K
Debt
$150K
Private Equity (2017): $889K, investors not publicly disclosed
Debt (2020): $150K led by PPP
What's next for Skyland Analytics?
The recent major strategic investment positions Skyland Analytics for accelerated growth and market expansion. This capital infusion is expected to fuel further development of their advanced analytics platform, enhance customer support, and broaden their reach within the highly regulated life sciences industry. The company's focus on critical areas like cell and gene therapy suggests a strategic intent to capture a significant share of this rapidly evolving market. Future developments will likely involve deeper integration with existing life science workflows and the introduction of new analytical tools to address complex data challenges.
See full Skyland Analytics company page
